BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26114209)

  • 1. Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus).
    Uehara S; Inoue T; Utoh M; Toda A; Shimizu M; Uno Y; Sasaki E; Yamazaki H
    Xenobiotica; 2016; 46(2):163-8. PubMed ID: 26114209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19.
    Toda A; Uehara S; Inoue T; Utoh M; Kusama T; Shimizu M; Uno Y; Mogi M; Sasaki E; Yamazaki H
    Xenobiotica; 2018 Jul; 48(7):720-726. PubMed ID: 28686070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.
    Koyanagi T; Nakanishi Y; Murayama N; Yamaura Y; Ikeda K; Yano K; Uehara S; Utoh M; Kim S; Uno Y; Yamazaki H
    Xenobiotica; 2015 Apr; 45(4):312-21. PubMed ID: 25364857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
    Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
    J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling.
    Shida S; Utoh M; Murayama N; Shimizu M; Uno Y; Yamazaki H
    Xenobiotica; 2015; 45(10):881-6. PubMed ID: 26075833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans.
    Lammers LA; Achterbergh R; de Vries EM; van Nierop FS; Klümpen HJ; Soeters MR; Boelen A; Romijn JA; Mathôt RA
    Drug Metab Dispos; 2015 Jun; 43(6):819-28. PubMed ID: 25795462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone.
    Uehara S; Uno Y; Nakanishi K; Ishii S; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2017 May; 45(5):457-467. PubMed ID: 28196829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
    Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
    Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach.
    Zhuang Y; de Vries DE; Xu Z; Marciniak SJ; Chen D; Leon F; Davis HM; Zhou H
    J Clin Pharmacol; 2015 Dec; 55(12):1386-94. PubMed ID: 26054042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.
    Turpault S; Brian W; Van Horn R; Santoni A; Poitiers F; Donazzolo Y; Boulenc X
    Br J Clin Pharmacol; 2009 Dec; 68(6):928-35. PubMed ID: 20002088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regio- and Stereo-Selective Oxidation of a Cardiovascular Drug, Metoprolol, Mediated by Cytochrome P450 2D and 3A Enzymes in Marmoset Livers.
    Uehara S; Ishii S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2017 Aug; 45(8):896-899. PubMed ID: 28495902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual Differences in Metabolic Clearance of S-Warfarin Efficiently Mediated by Polymorphic Marmoset Cytochrome P450 2C19 in Livers.
    Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jul; 44(7):911-5. PubMed ID: 27098744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Fasting Alters Pharmacokinetics of Cytochrome P450 Probe Drugs: Does Protein Binding Play a Role?
    Lammers LA; Achterbergh R; Romijn JA; Mathôt RAA
    Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):251-257. PubMed ID: 28929443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling.
    Shida S; Yamazaki H
    Xenobiotica; 2016 Sep; 46(9):759-64. PubMed ID: 26652678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models.
    Kusama T; Toda A; Shimizu M; Uehara S; Inoue T; Uno Y; Utoh M; Sasaki E; Yamazaki H
    Xenobiotica; 2018 Oct; 48(10):1072-1077. PubMed ID: 29034770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
    Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach.
    Cusinato DAC; Martinez EZ; Cintra MTC; Filgueira GCO; Berretta AA; Lanchote VL; Coelho EB
    J Ethnopharmacol; 2019 Dec; 245():112174. PubMed ID: 31442620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants.
    Nakanishi K; Uehara S; Kusama T; Inoue T; Shimura K; Kamiya Y; Murayama N; Shimizu M; Uno Y; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2018 Jun; 152():272-278. PubMed ID: 29626440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.